Turning Point Therapeutics Inc (TPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TPTX | ZTS | TAK | NBIX | UTHR |
| Company | Turning Point Therapeutics Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 75.99 | 158.42 | 13.15 | 136.05 | 234.76 |
| High | 76.01 | 165.04 | 13.19 | 139.37 | 240.93 |
| Low | 75.98 | 158.42 | 13.11 | 136.05 | 234.76 |
| Last | 76.01 | 161.09 | 13.16 | 138.75 | 240.05 |
| Change | +0.52 | +2.67 | +0.13 | +2.76 | +6.20 |
| % Change | +0.69% | +1.69% | +1.00% | +2.03% | +2.65% |
| Volume | 2,843,300 | 2,957,599 | 764,293 | 300,403 | 165,805 |
| 20-Day Average Volume | 962,475 | 4,326,775 | 1,726,319 | 730,319 | 459,930 |
| Previous Close | 75.49 | 158.42 | 13.03 | 135.99 | 233.85 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 75.11 | 157.09 | 13.36 | 136.36 | 235.06 |
| 20-Day Raw Stochastic | 100.00% | 68.04% | 22.08% | 61.30% | 91.11% |
| 20-Day Relative Strength | 74.20% | 47.03% | 37.60% | 54.06% | 55.49% |
| Weighted Alpha | -18.70 | -15.44 | -21.75 | +43.09 | +12.20 |
| Today's Opinion | 96% Buy | 72% Sell | 100% Sell | 80% Buy | 88% Buy |
| Previous Opinion | 96% Buy | 72% Sell | 100% Sell | 48% Buy | 64% Buy |
| Last Month's Opinion | 88% Buy | 40% Sell | 72% Sell | 88% Buy | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 08/09/22 | +10.99% since 04/22/24 | -1.38% since 04/22/24 | +4.18% since 04/22/24 | +2.52% since 04/22/24 |
| Low | 74.86 on 08/10/22 | 145.18 on 04/23/24 | 13.01 on 04/26/24 | 135.17 on 04/26/24 | 233.27 on 04/24/24 |
| High | 76.01 on 08/16/22 | 165.04 on 04/29/24 | 13.41 on 04/23/24 | 145.00 on 04/23/24 | 241.00 on 04/24/24 |
| 1-Month | |||||
| %Chg | +1.82% since 07/15/22 | -4.54% since 03/28/24 | -5.15% since 03/28/24 | +0.96% since 03/28/24 | +4.46% since 03/28/24 |
| Low | 74.57 on 07/21/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 221.53 on 04/01/24 |
| High | 76.01 on 08/16/22 | 169.49 on 04/01/24 | 13.78 on 04/01/24 | 145.00 on 04/23/24 | 241.37 on 04/11/24 |
| 3-Month | |||||
| %Chg | +134.02% since 05/16/22 | -16.20% since 01/29/24 | -10.80% since 01/29/24 | -2.09% since 01/29/24 | +10.63% since 01/29/24 |
| Low | 30.85 on 05/25/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 76.01 on 08/16/22 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 250.89 on 03/26/24 |
| 6-Month | |||||
| %Chg | +124.48% since 02/16/22 | +3.52% since 10/27/23 | -2.19% since 10/27/23 | +31.28% since 10/27/23 | +9.46% since 10/27/23 |
| Low | 23.77 on 03/15/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 76.01 on 08/16/22 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 258.31 on 12/14/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,806,125 | 72,454,816 | 41,237,580 | 13,531,958 | 11,004,745 |
| Shares Outstanding, K | 50,074 | 457,359 | 3,164,818 | 99,507 | 47,059 |
| Annual Sales | 30,830,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -236,550,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 120,000 | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | -123,090,000 | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | -0.18 | 0.85 | 0.53 | 0.25 | 0.52 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 08/08/22 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 1.44 on 02/07/24 | 4.36 on 02/21/24 |
| Latest Earnings Date | 08/08/22 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.83 | 6.70 | 56.93 | 11.89 |